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Abstract 23 
Objectives: We propose using MALDI-TOF MS as a tool for identifying microorganisms directly 24 
from liquid cultures after enrichment of the clinical sample in the media, in order to obtain a 25 
rapid microbiological diagnosis and an adequate administration of the antibiotic therapy in a 26 
clinical setting. 27 
Methods: To evaluate this approach, a series of quality control isolates, were grown in 28 
thioglycollate (TG) broth and brain heart infusion (BHI) broth and extracted under 4 different 29 
protocols before finally being identified by MALDI-TOF MS. After establishing the best 30 
extraction protocol, we validated the method in a total of 300 liquid cultures (150 in TG broth 31 
and 150 in BHI broth) of different types of clinical samples obtained from two tertiary Spanish 32 
hospitals.  33 
Results: The initial evaluation showed that the extraction protocol including a 5 min sonication 34 
step yielded 100% valid identifications, with an average score value of 2.305. In the clinical 35 
validation of the procedure, 98 % of the microorganisms identified from the TG broth were 36 
correctly identified relative to 97 % of those identified from the BHI broth. In 24 % of the 37 
samples analysed, growth by direct sowing was only successful in the liquid medium, and no 38 
growth was observed in the direct solid agar cultures.   39 
Conclusions: Use of MALDI-TOF-MS plus the sonication-based extraction method enabled 40 
direct and accurate identification of microorganisms in liquid culture media in 15 min, in 41 
contrast to the 24 hours of subculture required for conventional identification, allowing the 42 
administration of a targeted antimicrobial therapy.43 
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Introduction 44 
Rapid and reliable identification of bacteria is essential for the diagnosis and treatment of 45 
patients with infectious diseases. Until recently, biochemical, colorimetric and even antibiotic 46 
sensitivity tests were used to identify genera and species. The main limitations of these 47 
methods include the time required and the difficulty in distinguishing between poorly reactive, 48 
very similar, or difficult-to-culture microorganisms. Many of these problems have been solved 49 
by the Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-50 
TOF MS) [1-6]. Cost effectiveness studies have demonstrated that the early diagnosis of 51 
bacteraemia and other infectious diseases by MALDI-TOF MS has improved antimicrobial use, 52 
allowing a rapid administration of a targeted antimicrobial therapy [7-11].  However, one of 53 
the main limitations of MALDI-TOF MS is that more than 105 colony forming units (CFU)/ml are 54 
required for accurate identification of bacteria [12-13]. Direct identification of bacteria in 55 
clinical samples has therefore so far only been possible with urine samples [5-6].  56 
Use of liquid cultures has increased the sensitivity and turnaround time of bacterial culture, 57 
especially for samples with low bacterial loads that do not grow in solid culture, e.g. 58 
cerebrospinal fluid (CSF), pericardial fluid and joint fluid [14]. However, a period of 24 hours is 59 
required to identify the grown up microorganism by subsequent growth on solid culture and 60 
final identification. We propose using MALDI-TOF MS as a tool for identifying microorganisms 61 
directly from liquid cultures (thioglycollate broth and brain heart infusion broth) after 62 
extracting the bacterial protein in a sonication-based procedure.   63 
 64 
 65 
 66 
 67 
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Material and methods 68 
Clinical setting and sample collection 69 
The study was performed between November 2016 and February 2017 in two tertiary teaching 70 
hospitals in Spain, the Complejo Hospitalario Universitario A Coruña (CHUAC) and the Hospital 71 
General Universitario Gregorio Marañón (HGUGM). For the study, each laboratory cultured 72 
150 clinical samples in enriched liquid medium. In the CHUAC, the microorganisms were 73 
cultured in thioglycollate (TG) broth supplemented with vitamin K1 and hemin (Becton 74 
Dickinson, United States), while in the HGUGM the microorganisms were cultured in brain 75 
heart infusion (BHI) broth (Becton Dickinson).  76 
The following different types of samples were cultured in liquid medium: biopsy (n=50), 77 
exudate from surgical wounds (n=34), prosthetic material (n=25), cardiac valve (n=10), 78 
catheter tip (n=5), pericardial fluid (n=1), pleural fluid (n=10), synovial fluid (n=20), bile fluid 79 
(n= 20), peritoneal fluid (n=25) and CSF (n=100).  80 
Optimization of the extraction protocol for direct bacterial identification from liquid media 81 
To evaluate the optimal extraction protocol, various different quality control strains 82 
(Escherichia coli ATCC 25922, Haemophilus influenzae ATCC 49247, Pseudomonas aeruginosa 83 
ATCC 27083, Staphylococcus aureus ATCC 25923, Streptococcus pneumoniae ATCC 49619, 84 
Listeria monocytogenes ATCC 15313 and Neisseria meningitidis) were inoculated in parallel in 85 
both TG broth and BHI broth with the amount of bacteria filling a 1-μl inoculation loop and 86 
incubated for 16-24 hours at 37ºC. After growth was indicated by the turbidity of the media, 87 
an aliquot of 1.5 ml of each medium was transferred to an Eppendorf tube. The sample was 88 
centrifuged at 14.000 rpm for 2 min and the supernatant was discarded. Five hundred µl of 89 
water was added to the sample, and the agar and other debris were removed by pipetting 90 
before another 500 µl of water was added. The subsequent steps varied depending on the 91 
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protocol (Supplementary material). Each sample was extracted in triplicate and each extract 92 
was analysed in duplicate. The following protocol (nº 4) was finally established: 93 
Protocol 4. The sample was sonicated at 200 W (Ultrasons, JP Selecta S. A. Barcelona) for 5 min 94 
before being centrifuged at 14.000 rpm for 2 min. The supernatant was discarded and the 95 
pellet was washed with 500 µl of water. The sample was vortexed again and centrifuged at 96 
14.000 rpm for 2 min. Finally, the supernatant was discarded to yield the bacterial pellet for 97 
MALDI-TOF MS analysis. 98 
Clinical validation 99 
We performed a prospective clinical validation of the assay in 300 liquid cultures of clinical 100 
samples. The procedure was applied by researchers who were blinded to the type of samples. 101 
First, 139 liquid cultures incubated for 16-24 hours at 37ºC and with no visually detectable 102 
turbidity were processed using the extraction protocol selected. Secondly, 161 liquid cultures 103 
with visually observed turbidity were processed using the same protocol. All liquid cultures 104 
were subcultured, in parallel with the MALDI-TOF MS direct identification, in Trypticase Soy 105 
Agar (TSA, Becton Dickinson, EEUU), Chocolate Agar (Becton Dickinson) and Schaedler Agar 106 
(Becton Dickinson). TSA and Chocolate agar plates were incubated in 5-10 % CO2 atmosphere 107 
and Schaedler Agar in an anaerobic atmosphere at 37ºC. Colonies grown in the subcultures 108 
were identified by MALDI-TOF MS. Cultures were considered negative after 6 days of 109 
incubation without growth of microorganisms.  110 
MALDI-TOF MS processing and analysis 111 
The pellet obtained at the end of the extraction procedure was spread with a pipette tip on 112 
the MALDI-TOF MS steel plate spots and allowed to dry.  One µl of 70% formic acid (Sigma-113 
Aldrich, United States) was added to the sample and allowed to air-dry. The spots were then 114 
covered with the MALDI matrix (10mg/mL α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile 115 
/ 0.1% trifluoroacetic acid; Bruker Daltonik GmbH). Samples were analyzed in duplicates. 116 
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Spectra were acquired in a MALDI Microflex LT/SH bench-top mass spectrometer (Bruker 117 
Daltonik GmbH) equipped with a 60 Hz nitrogen laser. FlexControl v.3.0 software (Bruker 118 
Daltonik GmbH) was used to acquire the spectra and the MALDI Biotyper 3.1 (Bruker Daltonik 119 
GmbH) for real time interpretation and identification of the microorganisms. According to the 120 
manufacturer, a score > 2.0 indicates species identification, a score between 1.7 and 2.0 121 
indicates genus identification and a score < 1.7 indicates unreliable identification. 122 
 123 
Results  124 
Use of a sonication step is key to optimal bacterial extraction 125 
Protocol 1, based on the cell lysis using the lysis buffer from the Sepsityper Kit (Bruker Daltonik 126 
GmbH), provided 52.4% (44/84) valid identifications, and . meningitidis and H. influenzae 127 
isolates were misidentified providing MALDI-TOF MS no peaks in the spectra acquisition (Table 128 
1, supplementary material). The average   score value was 1.947 [1.444- 2.397]. Protocol 2, 129 
based on cell lysis with lysozyme, yielded 69.0 % (58/84) valid identifications, and H. influenzae 130 
isolates were misidentified, providing MALDI-TOF MS an unreliable identification. The average 131 
score value was 1.905 [1.163- 2.373]. Protocol 3, based on the use of SDS detergent, yielded 132 
63.1% (53/84) valid identifications, and N. meningitidis and H. influenzae isolates were 133 
misidentified. The average score value was 2.048 [1.714-2.383]. Protocol 4, based on a 5 min 134 
sonication step, yielded 100% (84/84) valid identifications with an average score value of 2.305 135 
[1.950- 2.525], and no microorganisms were misidentified. The average score value for 136 
microorganisms cultured in the BHI broth was 0.084 higher than the score for the 137 
microorganisms cultured in the TG broth.  138 
MALDI-TOF-MS direct identification from liquid cultures 139 
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In the first part of the study, 139 liquid cultures (61 TG and 78 BHI) with no visually observable 140 
turbidity were processed using the previously optimized sonication-based extraction protocol. 141 
MALDI-TOF MS did not detect any bacteria and no growth occurred on solid agar plates, so the 142 
specificity of the direct identification by MALDI-TOF MS is 100%, for all samples tested. 143 
In the second part of the study, 161 liquid cultures with visually observable turbidity were 144 
processed using the previously optimized sonication-based extraction protocol. Of the 89 145 
liquid cultures analyzed in TG broth, 84 were monomicrobial cultures (Table 1). The sensitivity 146 
of MALDI-TOF MS for detecting the pathogen in the monomicrobial cultures from the TG broth 147 
was 98 % (82/84), with a reliable identification to the species level in 74% (61/82) and an 148 
average score of 2.088. The undetected isolates were Staphylococcus caprae, isolated from 149 
prosthetic material, and Streptococcus anginosus, isolated from bile. MALDI-TOF MS 150 
successfully detected at least one microorganism in 100% (5/5) of the polymicrobial cultures 151 
from TG broth, with an average score of 1.982.  152 
Of the 72 liquid cultures grown in BHI broth (Table 2), 68 were monomicrobial cultures. The 153 
sensitivity of MALDI-TOF MS for detecting the pathogen in the monomicrobial cultures grown 154 
in BHI broth was 97% (66/68), with a reliable identification to the species level in 77% (51/ 66) 155 
with an average score of 2.090. The 2 undetected isolates were Candida albicans and Candida 156 
tropicalis. MALDI-TOF MS enabled identification of at least one microorganism in 100% (4/4) of 157 
the polymicrobial cultures grown in BHI broth, with average score of 2.158.   158 
For monomicrobial cultures carrying Gram-negative bacteria, MALDI-TOF MS yielded an 159 
average score of 2.172 with a reliable identification to the species level in 85% (33/39) for 160 
direct identification from TG broth (n=39) and 2.092 with a reliable identification to the species 161 
level in 72% (21/22) from BHI broth (n=22). For Gram-positive bacteria, MALDI-TOF MS yielded 162 
an average score of 2.017 with a reliable identification to the species level in 69% (29/42) for 163 
direct identification from TG broth (n=42) and 2.071 with a reliable identification to the species 164 
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level in 68% (30/44) from BHI broth (n=44). For identification of monomicrobial cultures 165 
carrying anaerobic bacteria, MALDI-TOF MS yielded an average score of 2.110 with a reliable 166 
identification to the species level in 25% (1/4) for direct identification from TG (n=4), 167 
identifying Bacteroides fragilis from CSF and peritoneal fluid samples and Propionibacterium 168 
acnes from two biopsy samples. For monomicrobial cultures carrying anaerobic bacteria, 169 
MALDI-TOF MS yielded an average score of 1.809, with no reliable identification to the species 170 
level in any of the samples in the direct identification from BHI (n=3), identifying Clostridium 171 
perfringens in a bile, Propionibacterium acnes in a joint prosthesis sample and C. innocuum in a 172 
surgical wound. For monomicrobial cultures carrying fungus, MALDI-TOF MS yielded an 173 
average score of 2.107 for direct identification from TG broth (n=3), identifying Candida 174 
glabrata in a derivation cardiac valve sample and in a catheter tip sample and Cryptococcus 175 
neoformans var. grubii in a CSF sample. MALDI-TOF MS did not reliably identify any BHI 176 
cultures carrying fungus, and subculture revealed Candida albicans in a bile and Candida 177 
tropicalis in a cardiac valve sample.  178 
Unreliable identification by MALDI-TOF MS was not associated with any particular type of 179 
clinical sample. The MALDI-TOF MS method for direct identification from liquid cultures did 180 
not yield any false positive results. In addition, the overall positive predictive value was 100 % 181 
and the negative predictive value, 97 %.  182 
In 24 % (39/ 160) of the samples analysed, growth by direct sowing was only successful in the 183 
liquid medium, and no growth was observed in the direct solid agar cultures.  These samples 184 
comprised  CSF (n=13), prosthetic material (n=4), biopsy (n=8), cardiac valve (n=5), catheter tip 185 
(n=2), peritoneal fluid (n=4), synovial fluid (n=1) and bile fluid (n=2). Agreement of 100% (39/ 186 
39) was found between the results obtained by direct identification from the liquid medium by 187 
MALDI-TOF MS and the results obtained by identification of the corresponding subculture. The 188 
average MALDI-TOF MS score was 2.150.  189 
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Discussion 190 
In the present study, we demonstrated that MALDI-TOF MS can also provide accurate, reliable 191 
and rapid identification of pathogens directly from liquid cultures after enrichment of clinical 192 
samples with the sonication-based extraction procedure. This method was able to correctly 193 
identify the main species causing meningitis and the most common bacterial species found in 194 
clinical microbiology. In the present study, 50 % (13/26) of the positive CSF samples only grew 195 
successfully in the liquid culture media, with MALDI-TOF MS providing 100% accurate 196 
identification within 16-24 hours of the sample arriving in the laboratory. The method is 197 
particularly accurate for pathogens that are scarce and difficult to detect, as was the case for 198 
P. aeruginosa isolated from a neurosurgery patient and others that were not detected by 199 
Gram staining, as was the case for the Listeria monocytogenes in an old man and even not 200 
suspected (e.g. C. neoformans_var_grubii isolated from a pulmonary transplant patient). 201 
Although the clinical impact is obvious for meningitis, other applications of this novel MALDI-202 
TOF MS identification procedure may be of great value. We have observed that 55 % (5/9) 203 
pathogens isolated from cardiac valves were recovered exclusively in the liquid media, having 204 
a great impact in the diagnosis of endocarditis and in the management of prosthetic heart 205 
valves [15-16]. Furthermore, 33 % (4/12) of the pathogens isolated from prosthetic material 206 
were recovered exclusively in the liquid media. This is of great importance for prosthetic joint 207 
samples, in which differentiation between infection and aseptic loosening of the replacement 208 
joint is difficult to achieve clinically [17-18].  209 
Regarding the extraction procedure from the liquid media, the sonication protocol yielded 210 
sensitivities close to 100 % without using as a final step the gold-standard ethanol/formic acid 211 
extraction procedure recommended by Bruker Daltonik GmbH. We recommend applying the 212 
hole procedure on a second time, only if the identification is not reliable in the first place. 213 
Regarding the culture media, we did not observe substantial differences between the TG and 214 
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BHI broth. The unidentified microorganisms isolated from the TG media were mainly 215 
Streptococcus anginosus group. (i.e. S. anginosus in a bile and S. constellatus and S. anginosus 216 
in two mixed cultures). The heterogeneity of members of the Streptococcus anginosus group 217 
has traditionally hampered their correct identification, and although MALDI-TOF MS has 218 
helped, identification to the subspecies level has not yet been clearly established [19]. The 219 
unidentified microorganisms from the BHI broth were yeasts (i.e. C. tropicalis and C. albicans), 220 
probably because these microorganisms grow less well in the media used [14]. Regarding 221 
polymicrobial cultures, at least one microorganism was correctly identified in 100 % of the 222 
samples. Use of the MALDI Biotyper MSP identification Mixture Method, relative to the 223 
Standard Method used in this study and recommended by the manufacturer for identifying 224 
mixed cultures, did not prove useful for the possible identification of mixed cultures in the 225 
liquid media (data not shown). Thus, this method must be used with caution in clinical settings. 226 
Further improvements in the software should be carried out to validate the possible use of this 227 
method in samples of polymicrobial predictable nature. Direct examination on the positive 228 
liquid culture could be performed prior extraction to confirm the presence of polymicrobial 229 
cultures and reject the direct MALDI-TOF MS identification. 230 
Strengths of our study include the double-center, prospective and blinded sample adjudication 231 
of the study. Besides, once the identification is well established, this study opens a way to 232 
detect antimicrobial resistance directly from the liquid culture media as previously performed 233 
in positive blood cultures and in urine samples [6, 20], being one more step towards the early 234 
administration of adequate antimicrobial therapy. 235 
Limitations of the study include the application of the technique exclusively in monomicrobial 236 
cultures, the slowness and less sensitivity compared with molecular methods [21-22] and the 237 
possibility to bring out contaminants that are further recovered in the liquid cultures, as 238 
negative-coagulase Staphylococci. We have informed all isolates recovered exclusively in the 239 
liquid media to clinicians responsible of the respective patients, although in case of negative-240 
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coagulase Staphylococci we have warned to evaluate with caution the significance of the 241 
microorganism in the clinical setting. 242 
The proposed MALDI-TOF MS method for direct identification from liquid media is able to 243 
provide an etiologic diagnosis of the infection only 15 min after observation of the turbidity of 244 
the medium, thus saving the 24 hours required for subculture in conventional analysis. Further 245 
studies should address the clinical impact of the proposed method by examining its capacity to 246 
adapt to different clinical situations and evaluating the yield for the different types of samples 247 
and liquid media. 248 
 249 
 250 
 251 
 252 
 253 
 254 
 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
 264 
 265 
 266 
 267 
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Table 1.  Direct identification of the 89 positive TG broth cultures by MALDI-TOF MS. 268 
Clinical sample (n)1 ID solid culture (n)2 ID liquid culture (n)3 
Reliable species 
identification 
by MALDI-TOF 
MS (y)4 
Biopsies (22) 
E. coli (2) E. coli (2) 100% (2.109) 
E. cloacae (1)  E. cloacae (1) / (1) 100% (2.268) 
M. morganii (1) M. morganii (1) 100% (2.267) 
S. aureus (10) S. aureus (10) / (2) 70% (2.058) 
S. epidermidis (1) S. epidermidis (1) 0% (1.799) 
S. hominis (1)  S. hominis (1) / (1) 100% (2.049) 
S. capitis (1) S. capitis (1) 100% (2.070) 
S. oralis (1)  S. oralis (1) / (1) 0% (1.538) 
S. pyogenes (1) S. pyogenes (1) 100% (2.303) 
E. faecalis(1)  E. faecalis(1) / (1) 100% (2.148) 
P. acnes (2) P. acnes (2) / (1) 0% (1.835) 
Surgical wound 
exudates (14) 
E. coli (6) E. coli (6) 83% (2.211) 
K. oxytoca (1) K. oxytoca (1) 100% (2.188) 
M. morganii (1) M. morganii (1) 100% (2.369) 
P. mirabilis (1) P. mirabilis (1) 100% (2.111) 
P. aeruginosa (2) P. aeruginosa (2) 50% (2.086) 
S. aureus (3) S. aureus (3) 100% (2.143) 
 
Prosthetic 
material (4) 
P. agglomerans (1) P. agglomerans (1) / (1) 0% (1.946) 
K. pneumoniae (1) K. pneumoniae (1) 100% (2.305) 
S. caprae (1) NRI5 0% (<1.6) 
S. agalactiae (1) S. agalactiae (1) 100% (2.013) 
 
  Cardiac valves (5) 
K. pneumoniae (1)  K. pneumoniae (1) / (1) 100% (2.305) 
S. hominis (2) S. hominis (2)/ (2) 50% (2.049) 
E. faecium (1)  E. faecium (1) / (1) 0% (1.771) 
C. glabrata (1) C. glabrata (1) 100% (2.203) 
Catheter tips (5) 
S. aureus (3) S. aureus (3) / (1)  66% (1.990) 
S. epidermidis (1) S. epidermidis (1) / (1) 100% (2.094) 
C. glabrata (1) C. glabrata (1) 100% (2.159) 
 
Pleural fluids (3) 
P. aeruginosa (1) P. aeruginosa (1) 0% (1.978) 
S. oralis + S. constallatus (1) S. oralis (1) 100% (2.064) 
C. albicans + G. adiacens (1) C. albicans (1) 0% (1.765) 
Syonovial fluid (2) S. aureus (2)  S. aureus (2) / (1) 100% (2.324) 
 
 
Bile fluids (7) 
E. coli (3) E. coli (3) 100% (2.315) 
E. cloacae (1) E. cloacae (1) / (1) 100% (2.210) 
K. oxytoca (1) K. oxytoca (1) 100% (2.160) 
S. anginosus (1) NP6 0% (<0) 
C. perfringens + S. anginosus 
(1) C. perfringens (1) 0% (1.750) 
Peritoneal fluids 
(12) 
E. coli (6) E. coli (6) 100% (2.184) 
B. fragilis (1)  B. fragilis (1) / (1) 100% (2.328) 
P. aeruginosa (1) P. aeruginosa (1) 100% (2.001) 
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S. epidermidis (2) S. epidermidis (2) / (2) 100% (2.038) 
E. faecium + C. glabrata (1) C. glabrata (1) 100% (2.074) 
 K. pneumoniae + E. faecium 
(1)  K. pneumoniae (1) 100% (2.255) 
CFS (14) 
E. coli (2) E. coli (2) 0% (1.759) 
K. pneumoniae (1) K. pneumoniae (1)  100% (2.025) 
P. aeruginosa (2)  P. aeruginosa (2) / (1) 100% (2.296) 
N. meningitidis (1)  N. meningitidis (1) / (1) 100% (2.304) 
B. fragilis (1) B. fragilis (1) 100% (2.300) 
E. faecium (1) E. faecium (1) 100% (2.337) 
S. epidermidis (1) S. epidermidis (1) / (1) 0% (1.797) 
S. hominis (1) S. hominis (1) / (1) 100% (2.090) 
S. haemolyticus (1) S. haemolyticus (1) 0% (1.870) 
S. capitis (1) S. capitis (1) / (1) 100% (2.165) 
S. pettenkoferi (1) S. pettenkoferi (1) /(1) 100% (2.110) 
L. monocytogenes (1) L. monocytogenes (1) / (1) 100% (2.239) 
C. neoformans var grubii (1)  C. neoformans var grubii (1) / (1) 0% (1.763) 
 269 
1 Description of the clinical samples analysed after culture in TG, classified depending on their 270 
origin and the number of samples (n).  271 
2 Identification by MALDI-TOF MS after subculture in solid media with the number of isolates by 272 
species (n).  273 
3 Direct identification by MALDI-TOF MS after sonication-based extraction from the TG broth, 274 
with the number of isolates per species (n) and the number of isolates that were exclusively 275 
isolated in the TG broth (x) and not recovered in the solid culture by direct seeding.  276 
4 Percentage of direct reliable identifications (score value >2.0) obtained by MALDI-TOF MS 277 
and average scores (y) obtained with the Biotyper MSP identification Standard Method (Bruker 278 
Daltonik GmbH). Not reliable identifications to the species level obtained scores among [1.7-279 
2.0], thus accurate to the genus level, excepting the cases further detailed in the table 280 
(NRI/NP). 281 
5 NRI: Not reliable identification (score < 1.6) 282 
6 NP: No peaks  283 
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Table 2. Direct identification of the 72 positive BHI broth cultures by MALDI-TOF MS. 284 
Clinical sample (n)1 ID solid culture (n)2 ID liquid culture (n) / (x)3 
Reliable species 
identification by 
MALDI-TOF MS 
(y)4 
Biopsies (23) 
E. coli (5) E. coli (5) 100% (2.481) 
M. morganii (1) M. morganii (1) 100% (2.123) 
E. cloacae (2) E. cloacae (2) 100% (2.209) 
S. aureus (4) S. aureus (4) 100% (2.234) 
S. pyogenes (2) S. pyogenes (2) 0% (1.843) 
E. faecalis (1) E. faecalis (1) 100% (2.330) 
E.faecalis (1) E.faecalis (1) 100% (2.233) 
S.epidermidis (2) S.epidermidis (2) 50% (2.014) 
S. capitis (1)  S. capitis (1) / (1) 100% (2.146) 
E. coli + S. agalactiae (1) E. coli (1) 100% (2.071) 
E.coli +  C.striatum (1) E. coli (1) 100% (2.237) 
Surgical wound 
exudates (14) 
P. aeruginosa (1) P. aeruginosa (1) 0% (1.710) 
S. marcescens (1) S. marcescens (1) 100% (2.243) 
K. pneumoniae (3) K. pneumoniae (3) 100% (2.316) 
C. innocuum (1) C. innocuum (1) 0% (1.705) 
S. anginosus (2) S. anginosus (2) 50% (2.094) 
S. aureus (3) S. aureus (3) 100% (2.248) 
S. agalactiae (1) S. agalactiae (1) 0% (1.946) 
S.epidermidis (2) S.epidermidis (2) 100% (2.238) 
Prosthetic material 
(7) 
S. aureus (2) S. aureus (2) / (2) 100% (2.285) 
S. pyogenes (2) S. pyogenes (2) 0% (1.748) 
E. faecalis(1) E. faecalis(1) 100% (2.491) 
P. acnes (1)  P. acnes (1) / (1) 0% (1.823) 
S. aureus + F.magna (1) S. aureus (1) 100% (2.352) 
Cardiac valves (4) 
S. mitis (1) S. mitis (1) / (1) 0% (1.981) 
S. aureus (1) S. aureus (1) 100% (2.822) 
S. epidermidis (1)  S. epidermidis (1)  100% (2.305) 
C. tropicalis (1) NRI5 0% (< 1.6) 
Bile fluids (6) 
E. coli + E. faecium (1) E. coli (1) 100% (2.624) 
P. mirabilis (1) P. mirabilis (1) 100% (2.370) 
S. odorifera (1) S. odorifera (1) 100% (2.326) 
C. perfringes (1) C. perfringes (1) 0% (1.898) 
S. constellatus (1)  S. constellatus (1) / (1) 100% (2.124) 
C. albicans (1) NP6 0% (<0) 
 
 
Peritoneal fluids (6) 
K. pneumoniae (1) K. pneumoniae (1) 100% (2.593) 
P. aeruginosa (1) P. aeruginosa (1) 100% (2.472) 
E. faecalis (2) E. faecalis (2) / (1) 100% (2.231) 
E.faecium (1) E.faecium (1) 100% (2.222) 
E.coli + K.pneumoniae (1) E. coli (1) 100% (2.071) 
 
 
E. coli (2)  E. coli (1) 100% (2.481) 
S. marcescens (2) S. marcescens (2) 100% (2.254) 
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CFS (12) S. pneumoniae (2)  S. pneumoniae (2) / (1) 100% (2.357) 
S. epidermidis (5)  S. epidermidis (5) / (4) 40% (2.001) 
S. simulans (1) S. simulans (1) 100% (2.130) 
 285 
 286 
1 Description of the clinical samples analysed after being cultured in BHI broth, classified 287 
depending on their origin and the number of samples (n).  288 
2 Identification obtained by MALDI-TOF MS after subculture on solid media with the number of 289 
isolates per species (n).  290 
3 Direct identification by MALDI-TOF MS after the sonication-based extraction from BHI broth, 291 
showing the number of isolates per species (n) and the number of isolates that were 292 
exclusively isolated in the BHI broth (x) and not recovered in the solid culture by direct 293 
seeding.  294 
4 Percentage of direct reliable identifications (score value >2.0) obtained by MALDI-TOF MS 295 
and average scores (y) obtained with the Biotyper SP identification Standard Method (Bruker 296 
Daltonik GmbH). Not reliable identifications to the species level obtained scores among [1.7-297 
2.0], thus accurate to the genus level, excepting the cases further detailed in the table 298 
(NRI/NP). 299 
5 NRI: Not reliable identification (score < 1.6) 300 
6 NP: No peaks 301 
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